Sign in

CIK 0000310158

  • Large accelerated filer

Merck & Co., Inc.

Sign in to watch
Ticker
MRK
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
EIN
221918501
Phone
+1 908-740-4000
Business address
126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
Former names
Merck & Co. Inc., SCHERING PLOUGH CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$8,611,875
in 1 filing

Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. DeLuca Richard R. −$8.6M EVP&Pres, Merck Animal Heallth sold 34% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-24 Klobuchar Michael A EVP - Chief Strategy Officer Grant or award +2,994 $73.51 $220K 14,058.93
2022-02-24 Karachun Rita A Sr. VP Fince-Global Controller Grant or award +3,478 $73.51 $256K 39,276.97
2022-02-24 Gerberding Julie L. EVP, Chief Patient Officer Grant or award +9,550 $73.51 $702K 48,712.14
2022-02-24 FRAZIER KENNETH C Executive Chair Grant or award +119,488 $73.51 $8.8M 706,283.06
2022-02-24 DeLuca Richard R. EVP&Pres, Merck Animal Heallth Grant or award +15,966 $73.51 $1.2M 133,896.54
2022-02-24 Chattopadhyay Sanat Exe V-P & Pres. MMD Grant or award +19,836 $73.51 $1.5M 112,981.36
2022-02-24 Davis Robert M CEO & President Grant or award +29,896 $73.51 $2.2M 247,592.76
2022-02-10 Williams David Michael EVP,Chief Info&Digital Officer Option exercise +1,202 $76.53 $92K 7,420.76
2022-02-10 Williams David Michael EVP,Chief Info&Digital Officer Shares withheld for taxes −477 $76.53 $37K 6,943.76
2022-02-10 Williams David Michael EVP,Chief Info&Digital Officer Option exercise · Restricted Stock Unit −1,202 1,205
2021-12-31 Coe Mary Ellen Director Grant or award · Phantom Stock +424.06 $76.64 $32K 12,841.99
2021-12-31 GLOCER THOMAS H Director Grant or award · Phantom Stock +146.79 $76.64 $11K 79,894.3
2021-12-31 Seidman Christine E Director Grant or award · Phantom Stock +212.03 $76.64 $16K 7,105
2021-12-31 WENDELL PETER C Director Grant or award · Phantom Stock +391.44 $76.64 $30K 110,151.91
2021-11-09 FRAZIER KENNETH C Executive Chair Option exercise +663,881 1,250,676.06
2021-11-09 FRAZIER KENNETH C Executive Chair Sale −634,266 $82.22 $52.1M 616,410.06
2021-11-09 FRAZIER KENNETH C Executive Chair Sale −29,615 $83.23 $2.5M 586,795.06
2021-11-09 FRAZIER KENNETH C Executive Chair Option exercise · Stock Option (Right to Buy) −663,881 0
2021-11-04 DeLuca Richard R. EVP&Pres, Merck Animal Heallth Option exercise +29,782 146,711.96
2021-11-04 DeLuca Richard R. EVP&Pres, Merck Animal Heallth Sale −29,782 $90.40 $2.7M 116,929.96

Page 39 of 42 · 823 trades